intravenous magnesium sulphateintravenous aminophyllinesubcutaneous adrenalineintravenous ketamineintravenous short-acting beta agonist (SABA)SABAsevere asthmaasthma
…03 to 2.21). There were no frequent serious adverse events. The intravenous magnesium sulphate group had a lower hospitalisation rate (RR=1.52, 95% CI 1.26 to…